Article
An AI-driven approach for nanobody affinity maturation
2025-11-12
Abstract excerpt
B7-H3 (CD276), an immunoregulatory checkpoint molecule overexpressed in numerous cancers, is a promising therapeutic target. Nanobodies possess unique advantages for targeting B7-H3, such as small size, high stability, and the ability to bind cryptic epitopes. However, the rational affinity maturation of these nanobodies is challenging, especially in the absence of detailed structural data on antigen-antibody inte...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 8298c99c-e008-568a-91f5-d5d7bd5eec99
- DOI
- 10.1101/2025.11.11.687768
